Do not stop or change your medication without speaking to a pharmacist or healthcare professional.
Active ShortageTier 3 — Critical

VISUDYNE

CHEPLAPHARM ARZNEIMITTEL GMBH

This is a national manufacturer shortage report. It does not confirm whether the product is unavailable at your local pharmacy — call ahead or ask your pharmacist.

Quick answers

Is there a shortage of VISUDYNE in Canada?

Yes. VISUDYNE 15MG has an active shortage reported to Health Canada (last updated October 1, 2026).

Why is VISUDYNE not available?

The reason the manufacturer reported: Disruption of the manufacture of the drug.

When will VISUDYNE be available again?

The manufacturer's estimated resolution date is December 31, 2026. This is an estimate and can change; follow this page to get an email when the status changes.

Can I still get this?Check with your pharmacist
StatusActive Shortage
Same-ingredient products on fileNone found
Expected resolution~2 months remaining (estimate)
Affected strength15MG
Report last updated2026-10-01
Checked by MedShort2026-11-12

What this means

Does this mean my pharmacy is out of stock?

Not necessarily — a national shortage doesn't mean every pharmacy has run out. Some locations may still have stock, especially of a specific strength or pack size.

What should I do?

Health Canada classes this as a Tier 3 shortage, its highest-impact category. If you rely on this medication, talk to your pharmacist or care team now rather than waiting for your supply to run low. This product is usually given in a hospital or clinic, where the pharmacy team manages supply. If you're scheduled to receive it, ask your care team.

Estimated Resolution

2026-12-31

~2 months remaining (estimate)

This is the manufacturer's estimated date, not a guarantee — actual resolution may come earlier or later.

Have you checked a pharmacy recently?

No community reports yet — be the first to share what you found.

Community reports are not verified by a pharmacy and may reflect a small sample size. This is not a guarantee of current stock.

DIN

02242367

Strength

15MG

Dosage Form

POWDER FOR SOLUTION

Route

INTRAVENOUS

Active Ingredient

VERTEPORFIN

Tier

Tier 3 — Critical

Last Updated

2026-10-01

Reason for Shortage

Disruption of the manufacture of the drug.